Table 1.
Condition | T1 | T2 | T3 | ||||
---|---|---|---|---|---|---|---|
Yes | No | Yes | No | Yes | No | ||
Ever Received PT |
Overall (N=344) | 108 (31.6%) | 234 (68.4%) | 90 (29.7%) | 213 (70.3%) | 77 (28.6%) | 192 (71.4%) |
NEU (n=84) | 31 (37.3%) | 52 (62.7%) | 24 (33.8%) | 47 (66.2%) | 25 (37.3%) | 42 (62.7%) | |
MED (n =82) | 20 (24.7%) | 61 (75.3%) | 23 (30.3%) | 53 (69.7%) | 14 (23.7%) | 45 (76.3%) | |
PT (n =98) | 32 (32.7%) | 66 (67.3%) | 21 (24.7%) | 64 (75.3%) | 19 (25.0%) | 57 (75.0%) | |
PT-MSE (n =80) | 25 (31.3%) | 55 (68.8%) | 22 (31.0%) | 49 (69.0%) | 19 (28.4%) | 48 (71.6%) | |
Intention to seek PT |
Overall (N=344) | 18 (6.4%) | 264 (93.6%) | 13 (5.5%) | 224 (94.5%) | 11 (5.2%) | 199 (94.8%) |
NEU (n =84) | 9 (13.0%) | 60 (87.0%) | 5 (8.6%) | 53 (91.4%) | 2 (4.1%) | 47 (95.9%) | |
MED (n =82) | 4 (5.6%) | 67 (94.4%) | 2 (3.4%) | 57 (96.6%) | 2 (4.0%) | 48 (96.0%) | |
PT (n =98) | 1 (1.3%) | 76 (98.7%) | 3 (4.7%) | 61 (95.3%) | 4 (6.8%) | 55 (93.2%) | |
PT-MSE (n =80) | 4 (6.2%) | 61 (93.8%) | 3 (5.4%) | 53 (94.6%) | 3 (5.8%) | 49 (94.2%) |
Note. T1 = prior to campaign exposure; T2 = 1 week following the final week of campaign exposure; T3 = at a 3-month follow-up evaluation; NEU = Neutral campaign; MED = Medication campaign; PT = Psychological treatment campaign; PT-MSE = Psychological treatment informing about medication side effects campaign.